Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence.

Feng Z, Lian H, Liu C, Shi Y, He C, Li S, Liang Q, Li J

Open source

DOI
10.1111/dom.71348
Published
2026 Sep 14
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71348,
  title = {Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence.},
  author = {Feng Z and Lian H and Liu C and Shi Y and He C and Li S and Liang Q and Li J},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.71348},
  url = {https://doi.org/10.1111/dom.71348}
}

RIS

TY  - JOUR
TI  - Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence.
AU  - Feng Z
AU  - Lian H
AU  - Liu C
AU  - Shi Y
AU  - He C
AU  - Li S
AU  - Liang Q
AU  - Li J
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.71348
UR  - https://doi.org/10.1111/dom.71348
ER  - 

APA

Z, F., H, L., C, L., Y, S., C, H., S, L., Q, L., & J, L. (2026). Potential Associations Between GLP-1 Receptor Agonists and Polyendocrine Metabolic Ovarian Syndrome: Triangulation of Genetic and Pharmacovigilance Evidence.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71348

Source records